4
Changes in Ownership
SAB Biotherapeutics, Inc. Filed Acc 0000950170-25-098365
Options or other derivatives
- Director acquired 571,250 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Moin Andrew · Director
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-07-22 | Grant or award : show line 1 in the form Series B Convertible Preferred Stock | +228,500 | 228,500 | I |
| 2025-07-22 | Grant or award : show line 2 in the form Warrants (right to buy) | +228,500 | 228,500 | I |
| 2025-07-22 | Grant or award : show line 3 in the form Warrants (right to buy) | +114,250 | 114,250 | I |
Loading xslF345X05/ownership.xml…